An annual Multi-Cancer Screening Test
Why should I consider Cancer Screening?
Cancer is a ticking time bomb globally. Every year about 18 million women and men are diagnosed with various cancers including carcinomas, sarcomas, neuroendocrine tumors, melanomas. These cancers are also associated with about 9 million deaths. This translates into roughly 34 cancer cases being detected and 18 cancer related deaths every minute. Annually, these cancers contribute to:
- 2.1 million newly diagnosed cases and 550,000 deaths in the US
- 4.1 million newly diagnosed cases and 1.8 million deaths in Europe (including the UK)
- 1.2 million newly diagnosed cases and 760,000 deaths in India.
Due to changes in lifestyle as well as other risk factors, these numbers are stated to increase in the future. Detecting Cancer Early is vital to saving lives. Studies have shown that early detection of cancer improves survival rates.
Trucheck™ is a blood test that can enable early detection of multiple cancers in asymptomatic individuals.
Why should I consider Trucheck™?
- Circulating Tumor Cells (CTCs) and their clusters are present in the blood of almost all cancer patients and are undetectable even in seemingly healthy individuals
- TrucheckTM technology to detect and characterise CTCs has been proven through extensive clinical validations involving more than 40,000 participants
- The test is a paradigm shift in cancer screening, as it does not involve radiation or invasive procedures. The test is performed at a world-class laboratory, which meets and exceeds all national and international standards.
Advantages of Trucheck™?
Being a non-invasive blood-based test, Trucheck can minimize the need to visit a healthcare centre – the blood sample can also be collected from the privacy and comfort of your home.
Advantages to the individuals:
- Wait times for appointments are reduced
- Minimized risk of COVID exposure
- May be assimilated into annual health check-up
- No risk of radiation or those associated with invasive procedures.
Advantages to the system:
- Reduces risk of COVID transmission and exposure of staff
- Reductions in avoidable / non-critical appointments
- Minimizes procedures that may be retrospectively deemed unnecessary
- Supports decision making in conjunction with existing tests / methods.
How does the test process work?
As soon as you book the test, our UK based Doctor will book an initial pre-consultation telephone call with you, to understand your medical history and reason for the test. Our Doctor will also discuss with you the risks and benefits associated with the test. If, for whatever reason, our Doctor feels you are not suitable for the test or you are not willing to proceed, you will be issued a refund.
A testing kit will be delivered to you to bring to the clinic appointment, it includes all the required paperwork and equipment to complete your sample collection.
Does Trucheck™ detect ‘existence of cancer’ or ‘possibility of cancer’?
It detects ‘existence of cancer’.
Does Trucheck™ replace conventional cancer screening like mammography?
TrucheckTM is not intended to be and should not be considered as a replacement for any Standard of Care screening tests.
Does a ‘negative’ Trucheck™ result mean that I am ‘totally’ cancer free?
Within the limits of error, a ‘negative’ result is a reasonable indication of undetectable cancer of the type covered by the test. For other cancers not covered by the test, no inference should be drawn from a ‘negative’ result.
Does a ‘negative’ Trucheck™ result mean that I am free from cancer forever?
A ‘negative’ results means that at the time of the test there were no detectable cancer cells circulating in the blood.
How frequently should Trucheck™ be repeated?
As Trucheck™ is a non-invasive blood test, there is no disadvantage in frequent testing. However, we advise that Trucheck™ should be performed every 12 months in case of every negative result.
If my Trucheck™ result is ‘positive’, how do I ﬁnd the location of the cancer?
The test indicates the location for the select types of cancers with high accuracy, and in others the Tissue of Origin can be identiﬁed with reasonable accuracy. In all cases of ‘positive’ results, the Report should be interpreted by your physician who can guide you on further course of action.
Is Trucheck™ recommended for a person suspected to have / has symptoms of cancer?
No, such individuals should seek expert medical advice without delay.
Can Trucheck™ be used to monitor recurrence after cancer treatment?
The Fitzrovia Hospital, 13-14 Fitzroy Square, London, W1T 6AH
Monday - Friday: 8:00am - 4:00 pm
Need to a quick response? Contact us using the numbers above. We are available to speak during our usual opening hours.